Forest's propranolol sustained release
Executive Summary
Firm receives first ANDA approval on April 11 to market generic of Ayerst's Inderal LA. Forest obtained approval for all four strengths of Inderal LA: 60, 80, 120 and 160 mg. The company plans to begin shipping the product in early may. Forest has not released prices for the generic yet, but estimates that it will be roughly 60% of Inderal LA's cost. Inderal LA sales are in the roughly $100 mil. range, according to Forest.
You may also be interested in...
Alvotech And Cipla Expand Biosimilars Deal For Australia And New Zealand
Cipla has expanded its partnership with Alvotech to cover the commercialization of five biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.
No Eudamed, No Problem! Latest Guidance Explains Alternatives While Database Is Built
Lack of official explanation about how the exchange of critical information will progress pending the launch of the EU’s medical device database, Eudamed3, has left many confused. New guidance lights the way forward.
David Now Goliath? Made In China PD-1s Sought After By Multinationals
From relatively little-known to high-flying, hotly pursued targets by global pharma players, Chinese domestically developed immuno-oncology drugs are ascending in both value and attractiveness, both inside China and far beyond.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: